Highly efficient SERS-based detection of cerebrospinal fluid neopterin as a diagnostic marker of bacterial infection

Analytical and Bioanalytical Chemistry

Volumn 408, Issue 16, 2016, Pages 4319-4327

  Kamińska, Agnieszka ^a   Witkowska, Evelin ^a   Kowalska, Aneta ^a   Skoczyńska, Anna ^b   Gawryszewska, Iwona ^b   Guziewicz, Elżbieta ^c   Snigurenko, Dymitr ^c   Waluk, Jacek ^a,d  

^a INSTITUTE OF PHYSICAL CHEMISTRY   (Poland)

^b NATIONAL MEDICINES INSTITUTE   (Poland)

^c INSTITUTE OF PHYSICS   (Poland)

^d CARDINAL STEFAN WYSZY SKI UNIVERSITY   (Poland)

Author keywords

Bacterial infections; Cerebrospinal fluid; Neisseria meningitidis; Neopterin; Surface enhanced Raman spectroscopy (SERS)

Indexed keywords

BRAIN; DIAGNOSIS; LIGHT TRANSMISSION; PRINCIPAL COMPONENT ANALYSIS; RAMAN SPECTROSCOPY; SCREENING;

BACTERIAL INFECTIONS; DIAGNOSTIC EFFICIENCY; HEALTH CARE APPLICATION; MENINGOCOCCAL MENINGITIS; NEISSERIA MENINGITIDIS; NEOPTERIN; SCREENING APPLICATION; SURFACE ENHANCED RAMAN SPECTROSCOPY;

CEREBROSPINAL FLUID;

NEOPTERIN;

CEREBROSPINAL FLUID; CHEMISTRY; EPIDEMIC MENINGITIS; EVALUATION STUDY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; LIMIT OF DETECTION; MICROBIOLOGY; NEISSERIA MENINGITIDIS; PHYSIOLOGY; PROCEDURES; RAMAN SPECTROMETRY;

CEREBROSPINAL FLUID; HUMANS; LIMIT OF DETECTION; MENINGITIS, MENINGOCOCCAL; NEISSERIA MENINGITIDIS; NEOPTERIN; SPECTRUM ANALYSIS, RAMAN;

EID: 84963744929     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-016-9535-7     Document Type: Article

References (61)

1. Huber C, Batchelor JR, Fuchs D, Hausen A, Lang A, Niederwieser D, et al. J Exp Med. 1984;160:310–6.
2. Murr C, Widner B, Wirleitner B, Fuchs D. Curr Drug Metab. 2002;3:175–87.
3. Kullich W. Clin Rheumatol. 1993;12:387–91.
4. Zeuzem S, Feinman SV, Rasenack J, Heathcote EJ, Lai MY, Gane E, et al. N Engl J Med. 2000;343:1666–72.
5. Garcia-Moll X, Cole D, Zouridakis E, Kaski JC. Heart. 2000;83:346–50.
6. Ledochowski M, Murr C, Widner B, Fuchs D. Clin Chim Acta. 1999;282:115–23.
7. Murr C, Bergant A, Widschwendter M, Heim K, Schröcksnadel H, Fuchs D. Clin Chem. 1999;45:1998–2004.
8. Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H. Cancer Res. 1990;50:2863–7.
9. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H. Immunol Today. 1988;9:150–5.
10. Fuchs D, Weiss G, Reibnegger G, Wachter H. Crit Rev Clin Lab Sci. 1992;29:307–41.
11. Dukes CS, Matthews TJ, Rivadeneira ED, Weinberg JB. J Leukoc Biol. 1994;56:650–3.
12. Fuchs D, Hausen A, Kofler M, Kasanowski H, Reibnegger G, Wachter H. Lung. 1984;162:337–46.
13. Muller Kobold AC, Kallenberg CGM, Cohen Tervaert JW. Ann Rheum Dis. 1999;58:237–45.
14. Hagberg L, Dotevall L, Norkrans G, Larsson M, Wachter H, Fuchs D. J Infect Dis. 1993;168:1285–8.
15. Gasse T, Murr C, Meyersbach P, Schmutzhard E, Wachter H, Fuchs D. Eur J Clin Chem Clin Biochem. 1994;32:685–9.
16. Cakan G, Bezirci FB, Kacka A, Cesur S, Aksaray S, Tezeren D, et al. Jpn J Infect Dis. 2008;61:366–70.
17. Schmutzhard E, Fuchs D, Hausen A, Reibnegger G, Wachter H. East Afr Med J. 1986;63:577–80.
18. Ruokonen E, Ilkka L, Niskanen M, Takala J. Acta Anaesthesiol Scand. 2002;46:398–404.
19. Werner ER, Bichier A, Daxenbichier G, Fuchs D, Fuith LC, Hausen A, et al. Clin Chem. 1987;33:62–6.
20. Barak M, Merzbach D, Gruener N. Scand J Clin Lab Investig. 1990;50:705–14.
21. Cannon JG, van der Meer JWM, Poutsiaka DD, Dinarello CA. J Appl Physiol. 1993;75:1897–902.
22. Mire-Sluis AR. Biologicals. 1993;21:131–44.
23. Mire-Sluis AR, Gaines-Das R, Thorpe R. J Immunol Methods. 1995;186:157–60.
24. Nie S, Emory SR. Science. 1997;275:1102–6.
25. Campion A, Kambhampati P. Chem Soc Rev. 1998;27:241–50.
26. Stiles PL, Dieringer JA, Shah NC, Van Duyne RP. Annu Rev Anal Chem. 2008;1:601–26.
27. Camden JP, Dieringer JA, Wang Y, Masiello DJ, Marks LD, Schatz GC, et al. J Am Chem Soc. 2008;130:12616–7.
28. Le Ru EC, Etchegoin PG. Annu Rev Phys Chem. 2012;63:65–87.
29. Kaminska A, Kowalska A, Snigurenko D, Guziewicz E, Lewiński J, Waluk J. Analyst. 2015;140:5090–8.
30. Kneipp K, Kneipp H, Kartha VB, Manoharan R, Deinum G, Itzkan I, et al. Phys Rev E. 1998;57:R6281–4.
31. Stokes RS, McBride E, Wilson CG, Girkin JM, Smith WE, Graham D. Appl Spectrosc. 2008;62:371–6.
32. Faulds K, Smith WE, Graham D, Lacey RJ. Analyst. 2002;127:282–6.
33. Sivanesan A, Witkowska E, Adamkiewicz W, Dziewit L, Kaminska A, Waluk J. Analyst. 2014;139:1037–43.
34. Alexander TA, Le DM. Appl Opt. 2001;46:3878–90.
35. Weichselbaum A. Fortschr Med. 1887;5:573–83.
36. Pathan N, Faust SN, Levin M. Arch Dis Child. 2003;88:601–7.
37. McIntyre PB, O’Brien KL, Greenwood B, van de Beek D. Lancet. 2012;380:1703–11.
38. The European Commission of the European Communities, European Union website. Commission decision of 22 December 1999 on the communicable diseases to be progressively covered by the community network under decision number 2119/98/EC of the Parliament and of the Council. Off J Eur Commun L28/50; 2000. Available: http://europa.eu.int/eur-lex/pri/en/oj/dat/2000/l_028/l_02820000203en00500053.pdf.
39. The European Parliament, the Council of the EU, European Union website. Decision number 2119/98/EC of the European Parliament and of the Council of 24 September 1998: setting up a network for the epidemiological surveillance and control of communicable diseases in the community. Off J Eur Commun L268/1; 1998. Available: http://eur-lex.europa.eu/LexUriServ/LexUriServ.douri=CELEX:31998D2119:EN:NOT.
40. Guiver M, Borrow R, Marsh J, Gray SJ, Kaczmarski EB. FEMS Immunol Med Microbiol. 2000;28:173–9.
41. Taha MK. J Clin Microbiol. 2000;38:855–7.
42. Mabbott S, Eckmann A, Casiraghi C, Goodacre R. Analyst. 2013;138:118–22.
43. Gonzalez-Solis JL, Martinez-Espinosa JC, Salgado-Roman JM, Palomares-Anda P. Lasers Med Sci. 2014;29:1241–9.
44. Hagberg L, Cinque P, Gisslen M, Brew BJ, Spudich S, Bestetti A, et al. AIDS Res Ther. 2010;7:15–7.
45. Prabavathi N, Nilufer A, Krishnakumar V. Spectrochim Acta A. 2013;114:101–13.
46. Harz M, Kiehnopf M, Stöckel S, Rosch P, Deufel T, Poop J. Analyst. 2008;133:1416–23.
47. Chan JW, Taylor DS, Lane SM, Zwerdling T, Tuscano J, Huser T. Anal Chem. 2008;80:2180–7.
48. Movasaghi Z, Rehman S, Rehman IU. Appl Spectrosc Rev. 2000;42:493–541.
49. Feng S, Lin D, Lin J, Li B, Huang Z, Chen G, et al. Analyst. 2013;138:3967–74.
50. Maiti NC, Apetri MM, Zagorski MG, Carey PR, Anderson VE. J Am Chem Soc. 2004;126:2399–408.
51. Dougherty DM, Marsh-Richard DM, Mathias CW, Hood AJ, Addicott MA, Moeller FG, et al. Psychopharmacology (Berl). 2008;198:431–45.
52. Pichardo-Molina JL, Frausto-Reyes C, Barbosa-García O, Huerta-Franco R, González-Trujillo JL, Ramírez-Alvarado CA, et al. Lasers Med Sci. 2007;22:229.
53. Gracie K, Corea E, Abbott S, Dougan JA, Graham D, Goodcare R, et al. Chem Sci. 2014;5:1030.
54. Shrivastava A, Gupta VB. Chron Young Sci. 2011;2:21–5.
55. Szymborski T, Witkowska E, Adamkiewicz W, Waluk J, Kaminska A. Analyst. 2014;139:5061–4.
56. Handin RI, Lux SE, Stossel TP, editors. Blood: principles and practice of hematology. vol. 2. Philadelphia: Lippincott Williams and Wilkins; 2003. p. 471.
57. Noorani L, Stenzel M, Liang R, Pourgholami MH, Morris DL. J Nanobiotechnol. 2015;13:1–12. doi:10.1186/s12951-015-0082-8.
58. Swartley JS, Marfin AA, Edupuganti S, Liu LJ, Cieslak P, Perkins B, et al. Proc Natl Acad Sci U S A. 1997;94:271–6.
59. Luna-Pineda T, Soto-Feliciano K, De la Cruz-Montoya E, Londono LCP, Rios-Velazquez C, Hernandez-Rivera SP. In: Fountain AW, editor. Chemical and biological sensing VIII. Bellingham: SPIE - The International Society of Optical Engineering; 2007.
60. Walter A, März A, Schumacher W, Rösch P, Popp J. Lab Chip. 2011;11:1013–21.
61. Jarvis RM, Brooker A, Goodacre R. Faraday Discuss. 2006;132:281–92.